LMA Protector Cuff Pilot vs LMA Supreme Among Anaesthetised, Non-Paralysed Patients
Comparison of Clinical Performance of LMA Protector Cuff Pilot and LMA Supreme Among Anaesthetised, Non-Paralysed Patients
1 other identifier
interventional
60
1 country
1
Brief Summary
Comparison of clinical performance between LMA Protector Cuff Pilot and LMA Supreme in terms of oropharyngeal leak pressure, time to insertion, ease of gastric tube insertion, laryngeal view, incidence of sore throat
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 17, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 19, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
February 19, 2019
CompletedFirst Submitted
Initial submission to the registry
May 16, 2019
CompletedFirst Posted
Study publicly available on registry
June 12, 2019
CompletedJune 12, 2019
June 1, 2019
7 months
May 16, 2019
June 9, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Oropharyngeal leak pressure (OLP)
To assess the OLP of LMA Protector Cuff Pilot and LMA Supreme
During induction of anaesthesia
Secondary Outcomes (4)
Mean time to insertion
During induction of anaesthesia
Gastric tube insertion
After induction of anaesthesia
Laryngeal view
After induction of anaesthesia
Complications
24 hours
Study Arms (2)
LMA Protector Cuff Pilot
EXPERIMENTALLMA Supreme
ACTIVE COMPARATORInterventions
Assessing the clinical performance of LMA Protector Cuff Pilot
Eligibility Criteria
You may qualify if:
- Patients planned for general anaesthesia without muscle relaxant usage via supraglottic airway device.
You may not qualify if:
- BMI \> 35
- Patients with likelihood of difficult intubation (Simplified Airway Risk Index Score of 4 or more)
- Patients with increased risks of aspirations (gastrooesophageal reflux disease, obstetric patients, hiatus hernia)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Liu Chian Yonglead
Study Sites (1)
Universiti Kebangsaan Malaysia Medical Centre
Kuala Lumpur, Kuala Lumpur, 56000, Malaysia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Consultant Anaesthesiologist
Study Record Dates
First Submitted
May 16, 2019
First Posted
June 12, 2019
Study Start
July 17, 2018
Primary Completion
February 19, 2019
Study Completion
February 19, 2019
Last Updated
June 12, 2019
Record last verified: 2019-06